English Ukrainian
Clinical medicine

EFFECT OF HYPOHOMOCYSTEINEMIC THERAPY ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS

Published 2026-02-04

Authors:

O.V. Kyrychenko
National Pirogov Memorial Medical University, Vinnytsya image/svg+xml
https://orcid.org/0000-0003-2901-3262
S.I. Semenenko
National Pirogov Memorial Medical University, Vinnytsya image/svg+xml
https://orcid.org/0000-0003-3148-2199
I.O. Doroshkevych
National Pirogov Memorial Medical University, Vinnytsya image/svg+xml
https://orcid.org/0000-0002-2242-0861
L.A. Vozniuk
National Pirogov Memorial Medical University, Vinnytsya image/svg+xml
https://orcid.org/0000-0001-9231-8267
A.O. Zhamba
National Pirogov Memorial Medical University, Vinnytsya image/svg+xml
https://orcid.org/0000-0001-9187-7964
O.M. Denysiuk
National Pirogov Memorial Medical University, Vinnytsya image/svg+xml
https://orcid.org/0000-0002-0698-6945
O.V. Sevriukov
National University of Pharmacy image/svg+xml
https://orcid.org/0000-0003-1830-8081
Abstract:
The purpose of the study was to evaluate the effect of hypohomocysteinemic therapy on cognitive function in patients with hypertension. This open-label, prospective, randomized clinical study included 46 patients aged 40–65 years with stage I–III hypertension depending on severity of target organ damage. Patients of the study group were supplemented with an oral hypohomocysteinemic combination in addition to standard antihypertensive therapy. The follow-up lasted three months. The control group consisted of 34 apparently healthy individuals. Total plasma homocysteine levels were measured using ELISA before and after treatment. Short-term memory performance was assessed by Luria´s Memory Words test. The addition of hypohomocysteinemic therapy to standard antihypertensive treatment significantly reduces plasma homocysteine levels and was associated with meaningful improvement in cognitive performance. These findings support a potential neuroprotective role of homocysteine-lowering therapy in patients with hypertension.
Keywords:
hypertension homocysteine B group vitamins cognitive function Luria´s Memory Words test
References:
  1. Andreichenko DI, Kalbus OI. Diagnostic value of the Luria 10-word memorization technique and Schulte tables in the diagnosis of mild cognitive dysfunction in patients with multiple sclerosis. Bulletin of problems biology and medicine. 2024;(4):243–252.
  2. Enderami A, Zarghami M, Darvishi-Khezri H. The effects and potential mechanisms of folic acid on cognitive function: a comprehensive review. Neurol Sci. 2018;39(10):1667–1675. doi:10.1007/s10072-018-3473-4.
  3. Ford AH, Almeida OP. Effect of vitamin B supplementation on cognitive function in the elderly: a systematic review and meta-analysis. Drugs Aging. 2019;36(5):419–434. doi:10.1007/s40266-019-00649-w.
  4. Ji Y. Homocysteine: A modifiable culprit of cognitive impairment for us to conquer? J Neurol Sci. 2019;404:128–136. doi:10.1016/j.jns.2019.06.012.
  5. Karger AB, Nomura SO, Guan W, Garg PK, Tison GH, Szklo M, et al. Association between elevated total homocysteine and heart failure risk in the Multi-Ethnic Study of Atherosclerosis cohort. J Am Heart Assoc. 2025;14(5):e038168. doi:10.1161/JAHA.124.038168.
  6. Lauriola M, D’Onofrio G, Ciccone F, Germano C, Cascavilla L, Paris F, et al. Relationship of homocysteine plasma levels with mild cognitive impairment, Alzheimer’s disease, vascular dementia, psychobehavioral, and functional complications. J Alzheimers Dis. 2021;82(1):235–248. doi:10.3233/JAD-210166.
  7. Luzzi S, Cherubini V, Falsetti L, Viticchi G, Silvestrini M, Toraldo A. Homocysteine, cognitive functions, and degenerative dementias: State of the art. Biomedicines. 2022;10(11):2741. doi:10.3390/biomedicines10112741.
  8. Periñán MT, Macías-García D, Jesús S, Martín-Rodríguez JF, Muñoz-Delgado L, Jimenez-Jaraba MV, et al. Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease. J Neurol. 2023;270(1):477–485. doi:10.1007/s00415-022-11361-y.
  9. Rabensteiner J, Hofer E, Fauler G, Fritz-Petrin E, Benke T, Dal-Bianco P, et al. The impact of folate and vitamin B12 status on cognitive function and brain atrophy in healthy elderly and demented Austrians, a retrospective cohort study. Aging (Albany NY). 2020;12(15):15478–15491. doi:10.18632/aging.103714.
  10. Thabet RH, Alessa REM, Al-Smadi ZKK, Alshatnawi BSG, Amayreh BMI, Al-Dwaaghreh RBA, et al. Folic acid: Friend or foe in cancer therapy. J Int Med Res. 2024;52(1):3000605231223064. doi:10.1177/03000605231223064.
  11. Ueno A, Hamano T, Enomoto S, Shirafuji N, Nagata M, Kimura H, et al. Influences of vitamin B12 supplementation on cognition and homocysteine in patients with vitamin B12 deficiency and cognitive impairment. Nutrients. 2022;14(7):1494. doi:10.3390/nu14071494.
  12. Xu M, Zhu Y, Chen J. Effects of folic acid supplementation on cognitive impairment: A meta-analysis of randomized controlled trials. J Evid Based Med. 2024;17:134–144. doi:10.1111/jebm.12588.
Publication:
«World of Medicine and Biology» Vol. 22 No. 1 (2026) , с. 87-92
УДК 616.12-008.331:616.89-008.45:615.225
DOI:
https://doi.org/10.26724/2079-8334-2026-1-95-87-92